Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome

被引:27
|
作者
Sladkova, Vladimira [1 ]
Mares, Jan [1 ]
Lubenova, Blanka [1 ]
Zapletalova, Jana [1 ]
Stejskal, David [1 ]
Hlustik, Petr [1 ]
Kanovsky, Petr [1 ]
机构
[1] Univ Hosp Olomouc, Dept Neurol, Olomouc, Czech Republic
关键词
Multiple sclerosis; CIS; RRMS; CSF; Inflammatory markers; Degenerative markers; TAU-PROTEIN; AXONAL DAMAGE; CYSTATIN-C; SUBGROUPS;
D O I
10.1179/016164110X12816242542535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Literature includes evidence of initial predominance of inflammation and later development of neurodegeneration in the pathogenesis of multiple sclerosis (MS). Objective: To search for differences in inflammatory and degenerative cerebrospinal fluid (CSF) markers between relapsing-remitting MS (RRMS) and the clinical isolated syndrome (CIS). Methods: A total of 148 subjects were evaluated, 65 MS patients (45 RRMS and 20 CIS) and 83 controls. The evaluated parameters included albumin quotient and prealbumin, transferrin, C3 and C4 complement factors, haptoglobin, beta-2-microglobulin, orosomucoid, alpha-1-antitrypsin, apolipoprotein A-I, apolipoprotein B, cystatin C, neuron-specific enolase, tau protein, beta-amyloid, oligoclonal IgG band (OCB), and IgG quotient (QIgG). Results: No differences were found in the inflammatory and degenerative CSF markers between patients with RRMS and CIS. QIgG was higher in RRMS than that in CIS but the number of OCB was higher after CIS. Cystatin C levels were significantly lower in RRMS compared to the other groups. It can be considered an indicator of the demyelination degree. Normal values of beta-amyloid were less frequent in RRMS compared to those in controls.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 50 条
  • [41] Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    T. Dong-Si
    J. Weber
    Y. B. Liu
    C. Buhmann
    H. Bauer
    C. Bendl
    P. Schnitzler
    C. Grond-Ginsbach
    A. J. Grau
    Journal of Neurology, 2004, 251 : 542 - 547
  • [42] Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    Dong-Si, T
    Weber, J
    Liu, YB
    Buhmann, C
    Bauer, H
    Bendl, C
    Schnitzler, P
    Grond-Ginsbach, C
    Grau, AJ
    JOURNAL OF NEUROLOGY, 2004, 251 (05) : 542 - 547
  • [43] Secretory Phospholipase A2 activity in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    Siroos, Bahaadin
    Balood, Mohammad
    Zahednasab, Hamid
    Mesbah-Namin, Seyed Alireza
    Pourgholy, Fatemeh
    Harirchian, Mohammad Hossein
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 262 (1-2) : 125 - 127
  • [44] Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis
    Jongen, PJH
    Lamers, KJB
    Doesburg, WH
    Lemmens, WAJG
    Hommes, OR
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (04): : 446 - 451
  • [45] Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients
    Yuceyar, N
    Taskiran, D
    Sagduyu, A
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2001, 103 (04) : 206 - 211
  • [46] Complement activation in cerebrospinal fluid in clinically isolated syndrome and early stages of relapsing remitting multiple sclerosis
    Hakansson, Irene
    Ernerudh, Jan
    Vrethem, Magnus
    Dahle, Charlotte
    Ekdahl, Kristina N.
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 340
  • [47] Effects of Oral Hormonal Contraceptives on the Clinical Course of Relapsing-Remitting Multiple Sclerosis
    Hernandez Clares, Rocio
    Carreon Guarnizo, Ester
    Cerdan Sanchez, Maria
    Sanchez-Vizcaino Buendía, Cristina
    Navarro García, Juan Carlos
    Martín Fernandez, J. Javier
    Meca Lallana, Jose
    NEUROLOGY, 2016, 86
  • [48] Age is associated with inflammatory disease acitivity in a relapsing-remitting multiple sclerosis clinical trial population
    Coerver, Eline
    Kacar, Sezgi
    Ciccarelli, Olga
    Sormani, Maria Pia
    Barkhof, Frederik
    Arnold, Douglas L.
    Schoonheim, Menno
    Mostert, Jop
    Koch, Marcus
    Uitdehaag, Bernard
    Eshaghi, Arman
    Killestein, Joep
    Strijbis, Eva
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 359 - 360
  • [49] Effects of oral hormonal contraceptives on the clinical course of relapsing-remitting multiple sclerosis
    Hernandez Clares, R.
    Carreon Guarnizo, E.
    Carrasco Torres, R.
    Sanchez-Vizcaino Buendia, C.
    Frutos Alegria, M. T.
    Salgado Cecilia, G.
    Martin Fernandez, J. J.
    Meca Lallana, J. E.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 402 - 403
  • [50] Clinical and electrophysiological and molecular genetic characteristics of the course of relapsing-remitting multiple sclerosis
    Delov, R. A.
    Rozhdestvensky, A. S.
    Marks, E. A.
    Smyalovsky, V. E.
    Khanokh, E. V.
    Kakulya, A. V.
    Sokolova, E. A.
    Agapova, O. Yu
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (10) : 55 - 59